Cocrystal Pharma (COCP) Change in Account Payables (2010 - 2013)
Cocrystal Pharma (COCP) posted Change in Account Payables of -$1.5 million for Q3 2013, down 488.14% sequentially from $385647.0 in Q2 2013, and down 172.17% YoY from $2.1 million in Q3 2012.
Cocrystal Pharma (COCP) Change in Account Payables (2010 - 2013) Analysis & Trends
Cocrystal Pharma has reported Change in Account Payables for 4 years, with the latest figure at -$1.5 million in Q3 2013.
- Quarterly Change in Account Payables fell 172.17% year-over-year to -$1.5 million in Q3 2013, while the trailing twelve-month figure through Sep 2013 was -$701812.0 (up 57.74% YoY) and the FY2012 annual result came in at -$880394.0, down 234.98% from the prior year.
- Change in Account Payables retreated to -$1.5 million in Q3 2013 per COCP's latest filing, from $385647.0 in the prior quarter.
- Over five years, Change in Account Payables peaked at $1.3 million in Q3 2011 and troughed at -$1.5 million in Q3 2013.
- A 4-year average of -$114126.1 and a median of -$270618.0 in 2011 frame the typical range for Change in Account Payables.
- The widest YoY moves for Change in Account Payables: up 287.06% in 2011, down 482.03% in 2011.
- Over 4 years, Change in Account Payables stood at -$189277.0 in 2010, then tumbled by 482.03% to -$1.1 million in 2011, then jumped by 70.83% to -$321404.0 in 2012, then plunged by 365.73% to -$1.5 million in 2013.
- According to Business Quant data, Change in Account Payables over the past three periods registered -$1.5 million, $385647.0, and $730813.0 for Q3 2013, Q2 2013, and Q1 2013 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -8.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 37.53 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Cocrystal Pharma | 15.65 Mn | 13.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2013 | -1.50 Mn |
| Sep 30, 2013 | -1.50 Mn |
| Jun 30, 2013 | 385,647.00 |
| Jun 30, 2013 | 385,647.00 |
| Mar 31, 2013 | 730,813.00 |
| Mar 31, 2013 | 730,813.00 |
| Dec 31, 2012 | -321,404.00 |
| Dec 31, 2012 | -321,404.00 |
| Sep 30, 2012 | -549,969.00 |
| Sep 30, 2012 | -549,969.00 |
| Jun 30, 2012 | 437,483.00 |
| Jun 30, 2012 | 437,483.00 |
| Mar 31, 2012 | -446,504.00 |
| Mar 31, 2012 | -446,504.00 |
| Dec 31, 2011 | -1.10 Mn |
| Dec 31, 2011 | -1.10 Mn |
| Sep 30, 2011 | 1.28 Mn |
| Sep 30, 2011 | 1.28 Mn |
| Jun 30, 2011 | 741,672.00 |
| Jun 30, 2011 | 741,672.00 |